BioEclipse Therapeutics INC.

Total Awards: 
1
Award Value: 
$7,999,689
Institution type: 
For profit
Short Name: 
BioEclipse Therapeutics INC.
  • Share
  • Print
  • PDF version

Awards to the Institution

Program Investigator Award Title Award Valuesort ascending
Clinical Trial Stage Projects Pamela Contag PHASE 1, OPEN LABEL, DOSE-ESCALATION STUDY OF CRX100 IN PATIENTS WITH ADVANCED SOLID TUMORS $7,999,689
Total:
$7,999,689.00
Icon for XLSX export